Faeth Therapeutics FTH
NASDAQ FTH
$17.08 -3.02 (-15.02%)
At close: Oct 23, 2026 · 4:00 PM EDT

Faeth Therapeutics (FTH) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Faeth Therapeutics' Return on Capital Employed [ROCE] was -105.89% in Q2 2026, down 14.16 percentage points from -91.73% a year earlier but up 79.84 percentage points from the prior quarter.

Analysis

Faeth Therapeutics (FTH) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Faeth Therapeutics came in at -74.59%, down 14.66 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has now declined for three consecutive years, with a four-year change of -29.12 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -59.93% in FY2024 (-19.08 pp), -40.85% in FY2023 (-1.25 pp), -39.60% in FY2022 (+5.87 pp) and -45.47% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has moved between -185.73% (Q1 2026) and -20.82% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has declined for 18 straight quarters, with an average year-over-year change of -35.81 percentage points over the last eight quarters.
  • The year-over-year drop in Return on Capital Employed [ROCE] has ranged between 3.99 percentage points (Q2 2024) and 100.57 percentage points (Q1 2026) over the last five years.
  • Per Business Quant data, FTH's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -185.73% (Q1 2026), -106.16% (Q4 2025) and -101.41% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.52%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 17.92%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.28%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 16.76%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -5.97%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.86%
10 Faeth Therapeutics 98.59 Mn -336.87 Mn - -105.89%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -105.89%
Mar 31, 2026 -185.73%
Dec 31, 2025 -106.16%
Sep 30, 2025 -101.41%
Jun 30, 2025 -91.73%
Mar 31, 2025 -85.16%
Dec 31, 2024 -74.36%
Sep 30, 2024 -63.58%
Jun 30, 2024 -55.57%
Mar 31, 2024 -53.07%
Dec 31, 2023 -51.21%
Sep 30, 2023 -52.86%
Jun 30, 2023 -51.58%
Mar 31, 2023 -46.14%
Dec 31, 2022 -43.82%
Sep 30, 2022 -37.26%
Jun 30, 2022 -30.97%
Mar 31, 2022 -29.16%
Dec 31, 2021 -24.60%
Sep 30, 2021 -20.82%
API Access

Faeth Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=FTH&period=max&api_key=YOUR_API_KEY